These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 28822563)
81. It's All About the Inflammation. Uretsky S; Aldaia L J Am Heart Assoc; 2020 Sep; 9(17):e018073. PubMed ID: 32856504 [No Abstract] [Full Text] [Related]
82. Anti-inflammatory therapy in well controlled HIV infection. Tarr PE; Calmy A Lancet HIV; 2018 Oct; 5(10):e538-e539. PubMed ID: 30257801 [No Abstract] [Full Text] [Related]
84. Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial. Eckard AR; Wu Q; Sattar A; Ansari-Gilani K; Labbato D; Foster T; Fletcher AA; Adekunle RO; McComsey GA Lancet Diabetes Endocrinol; 2024 Aug; 12(8):523-534. PubMed ID: 38964353 [TBL] [Abstract][Full Text] [Related]
85. Epicardial Adipose Tissue: A Novel Potential Imaging Marker of Comorbidities Caused by Chronic Inflammation. Tarsitano MG; Pandozzi C; Muscogiuri G; Sironi S; Pujia A; Lenzi A; Giannetta E Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889883 [TBL] [Abstract][Full Text] [Related]
86. Sex Differences in Non-AIDS Comorbidities Among People With Human Immunodeficiency Virus. Pond RA; Collins LF; Lahiri CD Open Forum Infect Dis; 2021 Dec; 8(12):ofab558. PubMed ID: 34888399 [TBL] [Abstract][Full Text] [Related]
87. Positron Emission Tomography to Characterize Dorsocervical Fat Pad Hypertrophy in People With Treated HIV Infection. Janus SE; Sullivan C; Morrison J; McComsey GA; Longenecker CT J Acquir Immune Defic Syndr; 2020 Mar; 83(3):e23-e25. PubMed ID: 31904705 [No Abstract] [Full Text] [Related]
88. HIV and pericardial fat are associated with abnormal cardiac structure and function among Ugandans. Buggey J; Yun L; Hung CL; Kityo C; Mirembe G; Erem G; Truong T; Ssinabulya I; Tang WHW; Hoit BD; McComsey GA; Longenecker CT Heart; 2020 Jan; 106(2):147-153. PubMed ID: 31537637 [TBL] [Abstract][Full Text] [Related]
89. Sex Differences in the Association of Fat and Inflammation Among People with Treated HIV Infection. Chen M; Hung CL; Yun CH; Webel AR; Longenecker CT Pathog Immun; 2019; 4(1):163-179. PubMed ID: 31508536 [TBL] [Abstract][Full Text] [Related]
90. Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update. Hulgan T Curr HIV/AIDS Rep; 2018 Jun; 15(3):223-232. PubMed ID: 29700760 [TBL] [Abstract][Full Text] [Related]
91. Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measures. De Lorenzo F; Collot-Teixeira S; Boffito M; Feher M; Gazzard B; McGregor JL Curr Med Chem; 2008; 15(28):2991-9. PubMed ID: 19075647 [TBL] [Abstract][Full Text] [Related]
92. Effect of Pericardial Fat Volume and Density on Markers of Insulin Resistance and Inflammation in Patients With Human Immunodeficiency Virus Infection. Longenecker CT; Margevicius S; Liu Y; Schluchter MD; Yun CH; Bezerra HG; McComsey GA Am J Cardiol; 2017 Oct; 120(8):1427-1433. PubMed ID: 28822563 [TBL] [Abstract][Full Text] [Related]
93. Effect of rosuvastatin on plasma coenzyme Q10 in HIV-infected individuals on antiretroviral therapy. Morrison JT; Longenecker CT; Mittelsteadt A; Jiang Y; Debanne SM; McComsey GA HIV Clin Trials; 2016 Jul; 17(4):140-6. PubMed ID: 27294339 [TBL] [Abstract][Full Text] [Related]